Literature DB >> 15830173

[Possible ways of managing cardiovascular prevention: polypharmacy, additional payment or application of evidence based medicine?].

H Gohlke1.   

Abstract

The financial balance of the health care system has changed dramatically due to a longer life expectancy and improved treatment options in elderly patients. More than 80% of cardiovascular events are lifestyle related and potentially preventable. Lifestyle modification is therefore the causal approach to decrease cardiovascular events. Improvement of nutrition and activity habits and prevention of cigarette smoking should start in the kindergarten, school and later at the workplace. A co-operation between medical societies and government institutions is necessary to achieve a population wide modification of lifestyle habits to lower the incidence of cardiovascular events in the population. Individual risk stratification is the basis for pharmacological prevention of cardiovascular events. The concept of the polypill has to be tested in controlled randomised studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830173     DOI: 10.1007/s00108-005-1390-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

Review 1.  [Cost-effectiveness of coronary heart disease prevention].

Authors:  G Wendland; G Klever-Deichert; K Lauterbach
Journal:  Z Kardiol       Date:  2002

2.  A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries.

Authors:  Anthony Rodgers
Journal:  BMJ       Date:  2003-06-28

3.  Estimates of global and regional potential health gains from reducing multiple major risk factors.

Authors:  Majid Ezzati; Stephen Vander Hoorn; Anthony Rodgers; Alan D Lopez; Colin D Mathers; Christopher J L Murray
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

4.  Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Hayden; Michael Pignone; Christopher Phillips; Cynthia Mulrow
Journal:  Ann Intern Med       Date:  2002-01-15       Impact factor: 25.391

5.  Primary prevention of coronary heart disease in women through diet and lifestyle.

Authors:  M J Stampfer; F B Hu; J E Manson; E B Rimm; W C Willett
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

6.  Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age.

Authors:  Martha L Daviglus; Kiang Liu; Lijing L Yan; Amber Pirzada; Larry Manheim; Willard Manning; Daniel B Garside; Renwei Wang; Alan R Dyer; Philip Greenland; Jeremiah Stamler
Journal:  JAMA       Date:  2004-12-08       Impact factor: 56.272

7.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

Authors:  Jean-Michel Gaspoz; Pamela G Coxson; Paula A Goldman; Lawrence W Williams; Karen M Kuntz; M G Myriam Hunink; Lee Goldman
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  Obesity in adulthood and its consequences for life expectancy: a life-table analysis.

Authors:  Anna Peeters; Jan J Barendregt; Frans Willekens; Johan P Mackenbach; Abdullah Al Mamun; Luc Bonneux
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

10.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28
View more
  2 in total

1.  [Recommendations for prevention and evidence-based medicine].

Authors:  H Gohlke; G Schuler
Journal:  Z Kardiol       Date:  2005

2.  [Total risk for cardiovascular disease. At what point is medical prophylactic medication useful?].

Authors:  H Gohlke; C von Schacky
Journal:  Z Kardiol       Date:  2005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.